stockrow
Friday 6 November 2026
Export HSTM’s income statement to Excel — free account
HealthStream, Inc.
HSTM Healthcare Health Information Services
HealthStream, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $304.1 million, up 4.26% from fiscal 2024.
- Revenue
- +8.94%
- EPS
- −8.90%
- Free cash flow
- −4.80%
Quarter to September 2026, against a year earlier
28.78
0.82
−2.77%
Follow HSTM
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
213.00 | 76.00 | 24.15 | 57.87 | 49.64 | 138.74 | 63.26 | 53.40 | 48.18 | 37.82 |
Piotroski F-Score |
5 | 7 | 7 | 6 | 6 | 8 | 8 | 9 | 9 | 6 |
P/S ratio |
4.22 | 3.49 | 3.36 | 3.47 | 2.85 | 3.24 | 2.83 | 2.93 | 3.31 | 2.28 |
Altman Z-Score |
5.15 | 4.94 | 4.91 | 4.54 | 3.28 | 4.17 | 3.63 | 4.07 | 4.92 | 3.53 |
Altman Z″-Score (non-manufacturers) |
4.27 | 4.71 | 5.19 | 4.47 | 2.67 | 3.06 | 2.80 | 3.22 | 3.95 | 3.21 |
P/FCF ratio |
39.74 | 18.22 | 21.60 | 20.16 | 20.60 | 21.33 | 15.29 | 13.21 | 17.18 | 11.60 |
P/Operating CF |
87.64 | 67.94 | 53.94 | 67.16 | 136.30 | 139.73 | 93.25 | 59.10 | 86.58 | 52.50 |
Beneish M-Score |
(2.43) | (3.09) | (2.75) | (3.07) | (2.08) | (3.01) | (2.71) | (3.04) | (2.90) | (2.75) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 78 |
P/B ratio |
2.83 | 2.50 | 2.44 | 2.60 | 2.09 | 2.45 | 2.26 | 2.40 | 2.69 | 1.96 |
Price to Tangible BV |
8.28 | 5.16 | 4.49 | 5.01 | 12.71 | 12.35 | 12.58 | 10.03 | 8.58 | 9.68 |
EV/Sales |
3.83 | 3.01 | 2.76 | 2.90 | 2.78 | 3.14 | 2.74 | 2.77 | 3.08 | 2.18 |
EV/EBITDA |
26.71 | 19.36 | 13.47 | 14.45 | 12.41 | 14.94 | 11.97 | 11.27 | 11.96 | 8.69 |
EV/Operating CF |
30.35 | 13.86 | 14.76 | 11.20 | 18.94 | 19.05 | 14.26 | 12.09 | 15.56 | 10.48 |
EV/FCF |
36.05 | 15.72 | 17.69 | 16.84 | 20.05 | 20.72 | 14.77 | 12.52 | 15.95 | 11.12 |
Quick Ratio |
1.59 | 1.67 | 1.96 | 1.93 | 0.78 | 0.87 | 0.82 | 0.93 | 1.15 | 0.77 |
Current Ratio |
1.87 | 1.98 | 2.26 | 2.14 | 0.96 | 1.06 | 0.98 | 1.10 | 1.32 | 0.96 |
Net Debt/EBITDA |
(3.75) | (3.92) | (3.56) | (3.40) | (0.85) | (0.96) | (0.88) | (1.04) | (1.30) | (0.75) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.50 | 0.53 | 0.54 | 0.55 | 0.49 | 0.52 | 0.54 | 0.56 | 0.58 | 0.59 |
Operating CF/Net income |
6.45 | 4.67 | 1.34 | 4.16 | 2.55 | 7.25 | 4.23 | 4.21 | 2.88 | 3.45 |
Capex/Depreciation |
(0.19) | (0.23) | (0.22) | (0.61) | (0.05) | (0.07) | (0.04) | (0.04) | (0.03) | (0.06) |
| 1.33% | 3.41% | 10.41% | 4.80% | 4.19% | 1.74% | 3.59% | 4.51% | 5.72% | 5.14% | |
| 0.97% | 2.48% | 7.55% | 3.39% | 2.85% | 1.18% | 2.46% | 3.05% | 3.96% | 3.56% | |
ROIC |
2.45% | 3.48% | 6.45% | 5.57% | 3.44% | 1.75% | 2.78% | 3.71% | 5.08% | 4.26% |
Return on Tangible Assets |
4.05% | 9.37% | 21.41% | 10.84% | 80.52% | 23.91% | 95.60% | 61.21% | 41.53% | 297.23% |
Average Days of Receivables |
90.02 | 64.57 | 64.62 | 43.63 | 68.73 | 49.65 | 58.42 | 50.29 | 44.21 | 46.81 |
Research and Development Expense of Revenue |
12.61% | 11.24% | 11.11% | 11.46% | 13.20% | 16.23% | 16.59% | 16.32% | 16.76% | 16.77% |
Selling, General and Administrative Expense of Revenue |
34.03% | 32.61% | 30.29% | 30.90% | 31.53% | 30.83% | 30.36% | 29.17% | 28.22% | 27.02% |
Intangible Assets out of Total Assets |
0.48 | 0.38 | 0.33 | 0.33 | 0.56 | 0.56 | 0.55 | 0.52 | 0.48 | 0.54 |
Share Based Compensation of Revenue |
0.99% | 0.81% | 0.77% | 1.67% | 0.91% | 2.07% | 1.33% | 1.49% | 1.53% | 2.68% |
Graham Net Nets |
0.08 | 0.12 | 0.15 | 0.08 | (0.07) | (0.05) | (0.07) | (0.04) | 0.00 | (0.07) |
Graham Number |
4.93 | 8.11 | 14.91 | 10.51 | 10.17 | 6.78 | 9.78 | 11.20 | 13.25 | 12.72 |
Earnings Yield |
0.47% | 1.32% | 4.14% | 1.73% | 2.01% | 0.72% | 1.58% | 1.87% | 2.08% | 2.64% |
Free Cash Flow Yield |
2.52% | 5.49% | 4.63% | 4.96% | 4.85% | 4.69% | 6.54% | 7.57% | 5.82% | 8.62% |
Revenue per Share |
6.06 | 6.74 | 7.18 | 7.85 | 7.66 | 8.14 | 8.71 | 9.13 | 9.60 | 10.13 |
Operating CF per Share |
0.76 | 1.47 | 1.34 | 2.03 | 1.12 | 1.34 | 1.67 | 2.09 | 1.90 | 2.11 |
Capex per Share |
(0.12) | (0.17) | (0.22) | (0.68) | (0.06) | (0.11) | (0.06) | (0.07) | (0.05) | (0.12) |
Free Cash Flow per Share |
0.64 | 1.29 | 1.12 | 1.35 | 1.06 | 1.24 | 1.61 | 2.02 | 1.85 | 1.99 |
Cash per Share |
3.25 | 4.12 | 5.23 | 5.34 | 1.45 | 1.65 | 1.76 | 2.33 | 3.20 | 1.90 |
Shareholders Equity per Share |
9.02 | 9.42 | 9.89 | 10.45 | 10.45 | 10.75 | 10.90 | 11.15 | 11.83 | 11.79 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
9.02 | 9.42 | 9.89 | 10.45 | 10.45 | 10.75 | 10.90 | 11.15 | 11.83 | 11.79 |
Free Cash Flow |
20.40 | 41.20 | 36.08 | 43.68 | 33.89 | 38.97 | 49.45 | 61.77 | 56.26 | 59.68 |
Working Capital |
82.47 | 98.66 | 134.58 | 119.39 | (4.72) | 6.50 | (2.84) | 11.85 | 37.43 | (4.49) |
Capital Expenditures |
(3.83) | (5.51) | (7.17) | (21.98) | (1.99) | (3.42) | (1.74) | (2.20) | (1.40) | (3.64) |
Net Current Asset Value |
67.55 | 88.78 | 118.43 | 73.20 | (51.53) | (40.89) | (49.30) | (28.98) | 1.71 | (46.69) |
EV/EBIT |
102.58 | 68.83 | 41.21 | 49.98 | 42.96 | 100.22 | 58.65 | 48.26 | 42.14 | 32.79 |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.09 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
Price to Operating Income |
113.07 | 79.80 | 50.30 | 59.82 | 44.13 | 103.20 | 60.73 | 50.95 | 45.39 | 34.22 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.99 | 2.97 | 2.01 | 1.39 | 1.75 | 2.56 | 3.14 | 4.04 | 5.00 | 5.26 |
Cash ROIC |
5.24% | 9.55% | 7.40% | 8.55% | 8.90% | 9.97% | 12.74% | 15.00% | 12.32% | 14.52% |
Accounts Receivable Turnover |
4.48 | 5.03 | 5.86 | 7.12 | 6.40 | 6.34 | 6.87 | 6.88 | 7.91 | 8.18 |
Accounts Payable Turnover |
19.36 | 23.88 | 15.15 | 15.61 | 12.63 | 12.59 | 14.69 | 12.88 | 13.90 | 14.89 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
15.23 | 17.49 | 32.30 | 16.90 | 38.13 | 20.55 | 29.18 | 28.68 | 24.70 | 26.45 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
42.87 | 42.70 | 39.51 | 35.69 | 38.24 | 40.51 | 38.82 | 40.58 | 36.88 | 37.16 |
Average Payables |
3.87 | 3.65 | 6.34 | 6.65 | 7.07 | 7.23 | 6.21 | 7.38 | 7.05 | 7.20 |
Average Assets |
387.78 | 403.56 | 426.53 | 465.75 | 494.93 | 493.53 | 492.25 | 498.84 | 505.35 | 515.57 |
Average Common Equity |
283.21 | 293.14 | 309.56 | 328.56 | 336.12 | 336.54 | 336.54 | 337.41 | 350.05 | 356.69 |
Columns are period end dates · fundamentals updated 5 Nov 2026